Vimarsana
Biggest News Aggregation in the World

Page 34 - Neurological Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neurological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neurological Sciences Today - Breaking & Trending Today

The Medical City introduces a one-stop care destination for brain health - Vimarsana News

The Medical City introduces a one-stop care destination for brain health

The Medical City (TMC) Ortigas Institute of the Neurological Sciences (INS) recently launched a specialized facility which houses the outpatient centers of the three departments namely—Neurology, Neurosurgery, and Psychiatry—with the goal of providing patients with complete and coordinated care. By consolidating services under these departments on one floor, the 6th…

Widely Used Antiepileptic Tied to Lower Vitamin D Levels - Vimarsana News

Widely Used Antiepileptic Tied to Lower Vitamin D Levels

The widely used antiepileptic medication carbamazepine is associated with lower vitamin D levels, highlighting the need for regular monitoring of patients who take the drug.

'Alarming' Rate of Abuse in Pregnant Women With Epilepsy - Vimarsana News

'Alarming' Rate of Abuse in Pregnant Women With Epilepsy

Women with epilepsy are more than twice as likely as those without the disorder to report physical, sexual, or emotional abuse during pregnancy, new research shows.

Blood from marathoner mice boosts brain function in their couch-potato counterparts - Vimarsana News

Blood from marathoner mice boosts brain function in their couch-potato counterparts

Physical exercise is great for a mouse’s brain, and for yours. Numerous studies conducted in mice, humans and laboratory glassware have made this

Poxel SA: Poxel Announces the Formation of its Scientific Advisory Board for Rare Metabolic Diseases - Vimarsana News

Poxel SA: Poxel Announces the Formation of its Scientific Advisory Board for Rare Metabolic Diseases

POXEL SA (Euronext POXEL FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis